ARCE - Trademark Details
Status: 802 - Request For Extension Of Time To File Opposition
Serial Number
90431302
Word Mark
ARCE
Status
802 - Request For Extension Of Time To File Opposition
Status Date
2022-01-07
Filing Date
2020-12-30
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-12-14
Attorney Name
Law Office Assigned Location Code
N10
Employee Name
SCHMIDT, JOHN JOSEPH
Statements
Goods and Services
Biological preparations for medical purposes, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; biological preparations for veterinary purposes for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; biological tissue cultures for medical purposes, namely, human blood samples, human allograft tissues, human umbilical cord blood and human induced pluripotent stem cells (iPSCs) from somatic cells; biological tissue cultures for veterinary purposes, namely, animal blood samples, tumors and allograft tissues; blood for medical purposes; cultures of microorganisms for medical or veterinary use; diagnostic biomarker reagents for medical purposes, namely, chemical and biological reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; pharmaceuticals, namely, drugs for medical purposes, namely, for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; enzymes for medical purposes; enzymes for veterinary purposes; immunostimulants; medicinal infusions for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceuticals, namely, medicines for human purposes, namely, for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceuticals, namely, medicines for veterinary purposes, namely, for veterinary cancers; preparations of microorganisms for medical or veterinary use, namely, cultures of bacteria and viruses for medical or veterinary use; pharmaceutical preparations for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; pharmaceutical preparations, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; pharmaceuticals, namely, gene modified immune cell therapies for the treatment of cancers, autoimmune diseases, inflammatory diseases, hypersensitivity, transplantation rejection, infectious diseases and neurodegenerative diseases; pharmaceuticals in the nature of pharmaceutical preparations for treating cancers, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases; transplants comprised of living cells, namely, genetically engineered tissues for medical and transplant purposes; genetically engineered cells for medical purposes, specifically for transplantation purposes; vaccines
Goods and Services
Biological research; conducting clinical trials for others; medical research; platform as a service (PAAS) featuring cell bioprocess platforms in the nature of computer software platforms for gene modified immune cells as therapeutic agents; research and development of new products for others; scientific laboratory services; scientific research in the field of cancers, autoimmune diseases, inflammatory diseases, neurodegenerative diseases, and immunotherapy; software as a service (SAAS) services featuring software for governing machineries for cell bioprocessing
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-03-24
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2021-03-24
Primary Code
042
First Use Anywhere Date
2020-02-03
First Use In Commerce Date
2020-09-24
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Zhi Dong
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2021-01-02 | NEW APPLICATION ENTERED IN TRAM |
| 2021-03-24 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2021-07-01 | ASSIGNED TO EXAMINER |
| 2021-07-06 | NON-FINAL ACTION WRITTEN |
| 2021-07-06 | NON-FINAL ACTION E-MAILED |
| 2021-07-06 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2021-11-08 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-11-08 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-11-09 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-11-10 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-11-24 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-12-14 | PUBLISHED FOR OPPOSITION |
| 2021-12-14 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2022-01-07 | EXTENSION OF TIME TO OPPOSE RECEIVED |
